Amarin Stock (NASDAQ:AMRN)


Chart

Previous Close

$19.27

52W Range

$7.00 - $20.43

50D Avg

$15.66

200D Avg

$12.55

Market Cap

$398.76M

Avg Vol (3M)

$75.89K

Beta

0.63

Div Yield

-

AMRN Company Profile


Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally to wholesalers and specialty pharmacy providers. It has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, and eicosapentaenoic acid. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.

Show More

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

Yes

Country

IE

Employees

275

IPO Date

Apr 01, 1993

Website

AMRN Performance


Latest Earnings Call Transcripts


Q2 21Aug 05, 21 | 1:29 PM
Q1 21Apr 29, 21 | 2:21 PM
Q4 20Feb 25, 21 | 2:16 PM

Peer Comparison


TickerCompany
DBVTDBV Technologies S.A.
CLLSCellectis S.A.
IVAInventiva S.A.
BCYCBicycle Therapeutics plc
BLRXBioLineRx Ltd.
AUTLAutolus Therapeutics plc
GNFTGenfit S.A.
MREOMereo BioPharma Group plc
TickerGate Footer Logo

Tickergate is an advanced stock research & comparison platform for informed data-driven investment decisions. 100% customizable, institutional-grade data, easy to use.

Company

AboutContact

Connect

LinkedIn

©2025 Tickergate

Tickergate does not provide financial advices and does not issue recommendations or offers to buy stocks of sell any securities. Information is provided 'as-is' and solely for informational purposes as an advice. Tickergate does not bear any responsibility or any losses or damages that may occur as a result of reliance on this data.
Start a conversation

Ask me anything about stocks, markets, or financial data.

Market Trends
Compare Stocks